Enteric fever, primarily caused by Salmonella Typhi and Salmonella Paratyphi, remains a significant health concern worldwide, particularly in developing countries. Despite advances in healthcare, effective management of enteric fever in clinical practice remains challenging. This article aims to explore the most effective strategies for managing this condition.
Rapid and accurate diagnosis is the cornerstone of effective management. Blood culture remains the gold standard for diagnosis, but its sensitivity can be limited. Newer diagnostic techniques, such as PCR and serological tests, offer promising alternatives.
Antibiotic therapy is the mainstay of treatment for enteric fever. However, the increasing prevalence of multidrug-resistant strains requires careful antibiotic selection. Fluoroquinolones, third-generation cephalosporins, and azithromycin are currently the drugs of choice.
Vaccination is a crucial preventive measure. Two vaccines - the oral live attenuated Ty21a vaccine and the injectable Vi polysaccharide vaccine - are currently available. However, their efficacy varies, and they are not suitable for all populations. Continued research into more effective vaccines is needed.
Public health measures, such as improved sanitation and safe drinking water, play a significant role in preventing enteric fever. These measures are particularly important in endemic areas where antibiotic resistance is high.
Effective management of enteric fever requires a multifaceted approach, including accurate diagnosis, appropriate antibiotic therapy, vaccination, and public health measures. Clinicians must stay abreast of the latest developments in diagnosis and treatment, while public health initiatives must focus on prevention. As antibiotic resistance continues to rise, the need for new treatment strategies and vaccines becomes increasingly urgent.
1.
A US health panel advises starting mammograms at age 40 rather than 50.
2.
TULSA Is Effective in Long-Term Prostate Cancer Control.
3.
J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79
4.
In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".
5.
How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma
1.
Molecular Matching for Individualized Blood-Disorder Therapy
2.
Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment
3.
Drug Safety Surveillance of Long-Term Medication Effects in Cancer Survivorship
4.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
5.
Early Diagnosis of Lung Cancer Through Emerging Biomarkers
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- The Incidence of Cancer in Men
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation